Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

Chemosensitivity testing--present and future in Japan.

Kubota T, Otani Y, Furukawa T, Hasegawa H, Watanabe M, Kitajima M.

Recent Results Cancer Res. 2003;161:231-41.

PMID:
12528811
3.

Individualized adjuvant chemotherapy guided by chemosensitivity test sequential to extended surgery for advanced gastric cancer.

Iwahashi M, Nakamori M, Nakamura M, Noguchi K, Ueda K, Nakatani Y, Ojima T, Ishida K, Naka T, Yamaue H.

Anticancer Res. 2005 Sep-Oct;25(5):3453-9.

4.

[Gastric cancer: laparoscopic surgery and adjuvant chemotherapy].

Tanigawa N.

Nihon Geka Gakkai Zasshi. 2004 Sep;105(9):489-93. Review. Japanese.

PMID:
15500091
5.

Chemosensitivity testing for gastrointestinal cancer: survival benefit potential and limitations.

Kim R, Emi M, Tanabe K, Uchida Y, Toge T.

Anticancer Drugs. 2003 Oct;14(9):715-23. Review.

PMID:
14551504
6.

Tegafur + gimeracil + oteracil. Just another fluorouracil precursor.

[No authors listed]

Prescrire Int. 2013 May;22(138):122.

PMID:
23819172
7.

Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively.

Maejima K, Tokunaga A, Kiyama T, Kanno H, Bou H, Watanabe M, Suzuki H, Uchida E.

Gastric Cancer. 2010 Nov;13(4):231-7. doi: 10.1007/s10120-010-0564-1. Epub 2010 Dec 3.

PMID:
21128058
8.

Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.

Meng C, Lu Z, Fang M, Zhou X, Dai K, Zhang S, Luo J, Luo Z.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):7622-32. eCollection 2014.

9.

[Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].

Sakurai Y, Kamoshida S, Furuta S, Sunagawa R, Inaba K, Isogaki J, Komori Y, Uyama I, Tsutsumi Y.

Gan To Kagaku Ryoho. 2008 Jul;35(7):1147-55. Japanese.

PMID:
18633253
10.

[Present state and prospects of adjuvant chemotherapy for gastric cancer].

Hori T, Ozawa R, Hanayama H, Yamashita H, Kaibe N, Matsumoto T, Oshima T, Takemura M, Kikuchi S, Sasako M.

Gan To Kagaku Ryoho. 2011 Sep;38(9):1390-5. Japanese.

PMID:
21918333
11.

[Effectiveness of precautionary chemotherapy in gastric cancer].

Rimassa L, Campagnoli E, Biancofiore G.

Tumori. 2000 Sep-Oct;86(5 Suppl 2):S5-13. Review. Italian.

PMID:
11195303
12.

New chemotherapy strategies for gastric cancer.

Kubota T.

In Vivo. 2008 May-Jun;22(3):273-8. Review.

13.

Adjuvant and neoadjuvant therapy for gastric cancer.

Kelsen DP.

Semin Oncol. 1996 Jun;23(3):379-89. Review.

PMID:
8658222
14.

A systematic overview of chemotherapy effects in gastric cancer.

Janunger KG, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):309-26. Review.

PMID:
11441938
15.
16.

[The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].

Ausch C, Rosen HR, Schiessel R.

Wien Klin Wochenschr. 1996;108(16):496-504. Review. German.

PMID:
8967093
17.

[A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].

Mihara K, Yamashiro N, Nishiya S, Kemmochi T, Ito Y, Egawa T, Nagashima A.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2358-60. Japanese.

PMID:
25731522
18.

Efficacy of adjuvant chemotherapy using tegafur-based regimen for curatively resected gastric cancer: update of a meta-analysis.

Oba K.

Int J Clin Oncol. 2009 Apr;14(2):85-9. doi: 10.1007/s10147-009-0877-4. Epub 2009 Apr 24. Review.

PMID:
19390937
19.

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group.

N Engl J Med. 2007 Nov 1;357(18):1810-20. Erratum in: N Engl J Med. 2008 May 1;358(18):1977.

20.

Current status and future perspectives in gastric cancer management.

Roukos DH.

Cancer Treat Rev. 2000 Aug;26(4):243-55. Review.

PMID:
10913380

Supplemental Content

Support Center